United States · FDA National Drug Code directory

atomoxetine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68382-218_8e543a65-7611-4362-94ba-0b3f929c776c
Product NDC
68382-218
Form
CAPSULE
Composition / generic term
atomoxetine
Labeler
Zydus Pharmaceuticals USA Inc.
Marketing category
ANDA
Marketing start / end (source format)
20170612
Source listing expiry
20261231

Source-listed ingredients

  • ATOMOXETINE HYDROCHLORIDE — 40 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 2000 CAPSULE in 1 BOTTLE (68382-218-02) · 68382-218-02
  • 30 CAPSULE in 1 BOTTLE (68382-218-06) · 68382-218-06
  • 1000 CAPSULE in 1 BOTTLE (68382-218-10) · 68382-218-10
  • 60 CAPSULE in 1 BOTTLE (68382-218-14) · 68382-218-14
  • 90 CAPSULE in 1 BOTTLE (68382-218-16) · 68382-218-16
  • 10 BLISTER PACK in 1 CARTON (68382-218-77) / 10 CAPSULE in 1 BLISTER PACK (68382-218-30) · 68382-218-77

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →